Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: Clinical utility in evaluating adjuvant therapy in neuroblastoma Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Immunoglobulin G
  • Iodine Radioisotopes
  • N-Acetylgalactosaminyltransferases
  • Neuroblastoma
  • Reverse Transcriptase Polymerase Chain Reaction

abstract

  • GD2 synthase mRNA is a useful surrogate marker for evaluating adjuvant treatment efficacy in neuroblastoma with prognostic potential.

publication date

  • March 15, 2003

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2003.02.055

PubMed ID

  • 12637475

Additional Document Info

start page

  • 1087

end page

  • 93

volume

  • 21

number

  • 6